uljima
2025-01-11   

Swiss National Bank Reduces Stock Position in Cabot Co. (NYSE:CBT)Noneuljima 。

Haiti wonders what's next as gang violence surges and the push for a UN peacekeeping mission flops

GSA Capital Partners LLP bought a new position in shares of Bloom Energy Co. ( NYSE:BE – Free Report ) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 25,400 shares of the company’s stock, valued at approximately $268,000. Other large investors have also bought and sold shares of the company. Xponance Inc. increased its position in shares of Bloom Energy by 7.8% during the 2nd quarter. Xponance Inc. now owns 12,542 shares of the company’s stock valued at $154,000 after purchasing an additional 903 shares during the last quarter. Arizona State Retirement System raised its position in Bloom Energy by 2.7% in the second quarter. Arizona State Retirement System now owns 56,886 shares of the company’s stock worth $696,000 after acquiring an additional 1,470 shares during the period. Quest Partners LLC raised its position in Bloom Energy by 2,780.0% in the second quarter. Quest Partners LLC now owns 3,600 shares of the company’s stock worth $44,000 after acquiring an additional 3,475 shares during the period. ORG Partners LLC purchased a new position in Bloom Energy in the second quarter valued at about $40,000. Finally, Gilliland Jeter Wealth Management LLC increased its stake in shares of Bloom Energy by 97.7% during the 3rd quarter. Gilliland Jeter Wealth Management LLC now owns 8,500 shares of the company’s stock worth $90,000 after purchasing an additional 4,200 shares during the last quarter. 77.04% of the stock is currently owned by institutional investors and hedge funds. Bloom Energy Stock Performance NYSE BE opened at $25.76 on Friday. The stock has a fifty day simple moving average of $12.22 and a 200-day simple moving average of $12.71. The stock has a market cap of $5.89 billion, a PE ratio of -46.01 and a beta of 2.71. Bloom Energy Co. has a twelve month low of $8.41 and a twelve month high of $26.26. The company has a current ratio of 3.36, a quick ratio of 2.33 and a debt-to-equity ratio of 3.09. Analyst Ratings Changes Check Out Our Latest Stock Analysis on BE Insider Activity at Bloom Energy In other Bloom Energy news, CEO Kr Sridhar sold 72,903 shares of the stock in a transaction that occurred on Wednesday, November 20th. The shares were sold at an average price of $25.02, for a total value of $1,824,033.06. Following the transaction, the chief executive officer now directly owns 1,869,593 shares in the company, valued at $46,777,216.86. This represents a 3.75 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink . Also, insider Shawn Marie Soderberg sold 1,289 shares of the firm’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $24.56, for a total value of $31,657.84. Following the transaction, the insider now directly owns 168,561 shares in the company, valued at approximately $4,139,858.16. The trade was a 0.76 % decrease in their position. The disclosure for this sale can be found here . Over the last quarter, insiders sold 122,975 shares of company stock worth $3,045,019. Corporate insiders own 8.81% of the company’s stock. Bloom Energy Company Profile ( Free Report ) Bloom Energy Corporation designs, manufactures, sells, and installs solid-oxide fuel cell systems for on-site power generation in the United States and internationally. The company offers Bloom Energy Server, a solid oxide technology that converts fuel, such as natural gas, biogas, hydrogen, or a blend of these fuels into electricity through an electrochemical process without combustion. Featured Stories Five stocks we like better than Bloom Energy What Are Dividend Achievers? An Introduction Vertiv’s Cool Tech Makes Its Stock Red-Hot How to Use the MarketBeat Stock Screener MarketBeat Week in Review – 11/18 – 11/22 How to Use High Beta Stocks to Maximize Your Investing Profits 2 Finance Stocks With Competitive Advantages You Can’t Ignore Want to see what other hedge funds are holding BE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bloom Energy Co. ( NYSE:BE – Free Report ). Receive News & Ratings for Bloom Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bloom Energy and related companies with MarketBeat.com's FREE daily email newsletter .

UCF coach Gus Malzahn reportedly resigning to take Florida State OC jobSwiss National Bank reduced its holdings in shares of Masimo Co. ( NASDAQ:MASI – Free Report ) by 0.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 88,300 shares of the medical equipment provider’s stock after selling 200 shares during the quarter. Swiss National Bank owned approximately 0.17% of Masimo worth $11,773,000 as of its most recent SEC filing. Several other hedge funds and other institutional investors have also bought and sold shares of MASI. NBC Securities Inc. raised its stake in shares of Masimo by 47.1% during the 3rd quarter. NBC Securities Inc. now owns 228 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 73 shares during the period. GAMMA Investing LLC raised its position in Masimo by 75.0% in the second quarter. GAMMA Investing LLC now owns 259 shares of the medical equipment provider’s stock worth $33,000 after acquiring an additional 111 shares during the period. Northwestern Mutual Wealth Management Co. boosted its stake in Masimo by 133.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 350 shares of the medical equipment provider’s stock valued at $44,000 after acquiring an additional 200 shares during the last quarter. HHM Wealth Advisors LLC grew its position in shares of Masimo by 25.0% during the 2nd quarter. HHM Wealth Advisors LLC now owns 625 shares of the medical equipment provider’s stock valued at $79,000 after acquiring an additional 125 shares during the period. Finally, Lazard Asset Management LLC increased its stake in shares of Masimo by 5,730.0% during the 1st quarter. Lazard Asset Management LLC now owns 583 shares of the medical equipment provider’s stock worth $85,000 after purchasing an additional 573 shares during the last quarter. Hedge funds and other institutional investors own 85.96% of the company’s stock. Masimo Price Performance MASI stock opened at $172.96 on Friday. Masimo Co. has a 12 month low of $91.60 and a 12 month high of $174.34. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $9.26 billion, a P/E ratio of 119.28 and a beta of 0.97. The firm has a 50 day moving average of $143.48 and a 200-day moving average of $128.00. Analysts Set New Price Targets MASI has been the topic of several research analyst reports. Wells Fargo & Company upped their price objective on Masimo from $160.00 to $171.00 and gave the company an “overweight” rating in a research note on Wednesday, November 6th. Stifel Nicolaus reaffirmed a “buy” rating and set a $190.00 price target (up previously from $170.00) on shares of Masimo in a research report on Friday. Raymond James raised Masimo from a “market perform” rating to an “outperform” rating and set a $170.00 price objective for the company in a report on Wednesday, November 6th. Piper Sandler upped their price objective on shares of Masimo from $165.00 to $180.00 and gave the company an “overweight” rating in a report on Wednesday, November 6th. Finally, BTIG Research lifted their target price on shares of Masimo from $166.00 to $170.00 and gave the stock a “buy” rating in a research note on Monday, October 14th. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, Masimo currently has a consensus rating of “Moderate Buy” and an average price target of $167.00. Check Out Our Latest Analysis on MASI Masimo Company Profile ( Free Report ) Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. Read More Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter .

Related hot word search:

Previous: jiliko online
Next: 09 jili